Diligence memo · auto-generated · as of July 2, 2026

Celerus Diagnostics Inc

Celerus Diagnostics Inc looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Celerus Diagnostics Inc operates in Other Technology, based in CARPINTERIA.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Celerus Diagnostics Inc has raised $20M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $10M on 2009-04-28.

Most recent recorded round closed around 2009-04-28.

Valuation (modeled)modeled

Provath models Celerus Diagnostics Inc at approximately $277M (range $13M–$1.5B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.54× the median modeled value of Series A Other Technology companies in 2007–2009 (150 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 17.2 yr ago; this sector typically re-raises about every 13 months.

Silent for over 3× the sector's normal cadence.

The last round stepped up 3.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 84% of Other Technology peers (21302 compared).

Modeled value ranks above 87% of those peers.

Closest niche peers: Blackboard Inc, Westec Acquisition Corp, Advanced Electron Beams, Inc., Mint Software Inc., TargetCast Networks, Inc..

Peoplefiled

4 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.